Phibro Animal Health (PAHC) Free Cash Flow Growth (1y) (2014 - 2026)
Powered by 
Analysis
Phibro Animal Health (PAHC) Free Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.51 Bn | 40.32 Bn | 779.09 Mn | 112.68% |
| 2 | Zoetis | 30.62 Bn | 28.94 Bn | 1.05 Bn | 17.21% |
| 3 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 35.56% |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | -35.73% |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 74.81 Mn | 67.72 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -2.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -35.73% |
| Mar 31, 2026 | -97.49% |
| Dec 31, 2025 | 273.94% |
| Sep 30, 2025 | -248.21% |
| Jun 30, 2025 | -47.06% |
| Mar 31, 2025 | 2,011.39% |
| Dec 31, 2024 | -123.04% |
| Sep 30, 2024 | -65.16% |
| Jun 30, 2024 | 64.30% |
| Mar 31, 2024 | 201.70% |
| Dec 31, 2023 | 267.36% |
| Sep 30, 2023 | 125.75% |
| Jun 30, 2023 | 190.61% |
| Mar 31, 2023 | 57.53% |
| Dec 31, 2022 | -199.00% |
| Sep 30, 2022 | -833.68% |
| Jun 30, 2022 | -156.36% |
| Mar 31, 2022 | -142.50% |
| Dec 31, 2021 | -36.56% |
| Sep 30, 2021 | 36.60% |